Business Description
CQ Pharmaceutical Holding Co Ltd
SIC : 5122
ISIN : CNE0000010K0
Share Class Description:
SZSE:000950: Class ATotal Employee Number:
12,237Compare
Compare
Traded in other countries / regions
000950.China Index Membership
SZSE Component Index IPO Date
1999-09-16Description
CQ Pharmaceutical Holding Co Ltd is engaged in Wholesale and retail of pharmaceuticals and medical devices.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.19 | |||||
Equity-to-Asset | 0.17 | |||||
Debt-to-Equity | 2.21 | |||||
Debt-to-EBITDA | 19.88 | |||||
Interest Coverage | 2.49 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 1.68 | |||||
Beneish M-Score | -2.32 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.2 | |||||
3-Year EBITDA Growth Rate | -14.5 | |||||
3-Year EPS without NRI Growth Rate | -25.6 | |||||
3-Year FCF Growth Rate | 195.9 | |||||
3-Year Book Growth Rate | 3 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 14.17 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 7.52 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 29.02 | |||||
9-Day RSI | 35.58 | |||||
14-Day RSI | 40.23 | |||||
3-1 Month Momentum % | 18.23 | |||||
6-1 Month Momentum % | 8.82 | |||||
12-1 Month Momentum % | 20.04 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.19 | |||||
Quick Ratio | 0.98 | |||||
Cash Ratio | 0.1 | |||||
Days Inventory | 48.56 | |||||
Days Sales Outstanding | 170.75 | |||||
Days Payable | 95.69 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.16 | |||||
Dividend Payout Ratio | 0.09 | |||||
3-Year Dividend Growth Rate | -22.7 | |||||
Forward Dividend Yield % | 1.16 | |||||
5-Year Yield-on-Cost % | 1.05 | |||||
3-Year Average Share Buyback Ratio | 0.3 | |||||
Shareholder Yield % | -10.03 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 6.95 | |||||
Operating Margin % | 2.09 | |||||
Net Margin % | 0.44 | |||||
EBITDA Margin % | 1.61 | |||||
FCF Margin % | -1 | |||||
OCF Margin % | -0.71 | |||||
ROE % | 3.09 | |||||
ROA % | 0.53 | |||||
ROIC % | 3.3 | |||||
3-Year ROIIC % | -9.82 | |||||
ROC (Joel Greenblatt) % | 4.96 | |||||
ROCE % | 6.59 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 24.62 | |||||
Forward PE Ratio | 17.84 | |||||
PE Ratio without NRI | 24.62 | |||||
Shiller PE Ratio | 11.24 | |||||
Price-to-Owner-Earnings | 87.63 | |||||
PS Ratio | 0.11 | |||||
PB Ratio | 0.76 | |||||
Price-to-Tangible-Book | 0.9 | |||||
EV-to-EBIT | 42.37 | |||||
EV-to-EBITDA | 26.56 | |||||
EV-to-Revenue | 0.43 | |||||
EV-to-FCF | -42.91 | |||||
Price-to-GF-Value | 0.91 | |||||
Price-to-Projected-FCF | 1.2 | |||||
Price-to-Median-PS-Value | 0.67 | |||||
Price-to-Graham-Number | 0.57 | |||||
| Price-to-Net-Current-Asset-Value | 3.8 | |||||
Earnings Yield (Greenblatt) % | 3.74 | |||||
FCF Yield % | -9.21 | |||||
Forward Rate of Return (Yacktman) % | -17.64 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
CQ Pharmaceutical Holding Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 81,390.809 | ||
| EPS (TTM) (Â¥) | 0.21 | ||
| Beta | 0.9529 | ||
| 3-Year Sharpe Ratio | -0.09 | ||
| 3-Year Sortino Ratio | -0.13 | ||
| Volatility % | 22.14 | ||
| 14-Day RSI | 40.23 | ||
| 14-Day ATR (Â¥) | 0.164686 | ||
| 20-Day SMA (Â¥) | 5.429 | ||
| 12-1 Month Momentum % | 20.04 | ||
| 52-Week Range (Â¥) | 4.79 - 7.41 | ||
| Shares Outstanding (Mil) | 1,712.78 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
CQ Pharmaceutical Holding Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
CQ Pharmaceutical Holding Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| CNY 0.030000 Cash Dividend | 2026-06-18 | 5.19 (-1.52%) | ||
| CNY 0.030000 Cash Dividend | 2026-01-16 | 6.26 (-4.43%) | ||
| CNY 0.030000 Cash Dividend | 2025-06-20 | 4.94 (-1.79%) | ||
| CNY 0.030000 Cash Dividend | 2024-11-18 | 5.50 (-1.43%) | ||
| 1.5:1 Stock Split | 2010-04-16 | 12.47 (-1.22%) | ||
| 1.25:1 Stock Split | 2008-04-23 | 9.43 (-0.51%) |
Show
Entries
CQ Pharmaceutical Holding Co Ltd Frequently Asked Questions
What is CQ Pharmaceutical Holding Co Ltd(SZSE:000950)'s stock price today?
The current price of SZSE:000950 is ¥5.17. The 52 week high of SZSE:000950 is ¥7.41 and 52 week low is ¥4.79.
When is next earnings date of CQ Pharmaceutical Holding Co Ltd(SZSE:000950)?
The next earnings date of CQ Pharmaceutical Holding Co Ltd(SZSE:000950) is .
Does CQ Pharmaceutical Holding Co Ltd(SZSE:000950) pay dividends? If so, how much?
The Dividend Yield %  of CQ Pharmaceutical Holding Co Ltd(SZSE:000950) is 1.16% (As of Today), Highest Dividend Payout Ratio of CQ Pharmaceutical Holding Co Ltd(SZSE:000950) was 0.67. The lowest was 0.08. And the median was 0.14. The  Forward Dividend Yield % of CQ Pharmaceutical Holding Co Ltd(SZSE:000950) is 1.16%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers